These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1645517)

  • 61. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Positron emission tomography. A new measurement method for imaging of regional and biochemical parameters].
    Bolwig TG; Haunsø S; Hove JD; Hesse B; Højgaard L; Jensen M; Paulson OB; Svendsen JH; Sørensen SS
    Ugeskr Laeger; 1994 Oct; 156(43):6341-7. PubMed ID: 7810006
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
    Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
    Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neurochemical brain imaging investigations of schizophrenia.
    Soares JC; Innis RB
    Biol Psychiatry; 1999 Sep; 46(5):600-15. PubMed ID: 10472414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Focal cortical release of endogenous opioids during reading-induced seizures.
    Koepp MJ; Richardson MP; Brooks DJ; Duncan JS
    Lancet; 1998 Sep; 352(9132):952-5. PubMed ID: 9752818
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Positron emission tomography receptor studies in epilepsy.
    Duncan JS
    Rev Neurol (Paris); 1999 Jul; 155(6-7):482-8. PubMed ID: 10472664
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuropharmacology and receptor studies in the elderly.
    Meltzer CC
    J Geriatr Psychiatry Neurol; 1999; 12(3):137-49. PubMed ID: 10593702
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping.
    Weeks RA; Cunningham VJ; Piccini P; Waters S; Harding AE; Brooks DJ
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):943-9. PubMed ID: 9307607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gender and age influences on human brain mu-opioid receptor binding measured by PET.
    Zubieta JK; Dannals RF; Frost JJ
    Am J Psychiatry; 1999 Jun; 156(6):842-8. PubMed ID: 10360121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
    List SJ; Cleghorn JM
    Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
    Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
    Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Positron emission tomography in neuropsychiatric lupus erythematosus.
    Stoppe G; Wildhagen K; Seidel JW; Meyer GJ; Schober O; Heintz P; Künkel H; Deicher H; Hundeshagen H
    Neurology; 1990 Feb; 40(2):304-8. PubMed ID: 2132733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
    Nordström AL; Farde L; Nyberg S; Karlsson P; Halldin C; Sedvall G
    Am J Psychiatry; 1995 Oct; 152(10):1444-9. PubMed ID: 7573582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Receptor imaging by positron emission tomography and single-photon emission computed tomography.
    Frost JJ
    Invest Radiol; 1992 Dec; 27 Suppl 2():S54-8. PubMed ID: 1334949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness.
    Buchsbaum MS
    Clin Neurosci; 1995; 3(2):122-30. PubMed ID: 7583618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.
    Ho AP; Gillin JC; Buchsbaum MS; Wu JC; Abel L; Bunney WE
    Arch Gen Psychiatry; 1996 Jul; 53(7):645-52. PubMed ID: 8660131
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Opiate receptors in idiopathic generalised epilepsy measured with [11C]diprenorphine and positron emission tomography.
    Prevett MC; Cunningham VJ; Brooks DJ; Fish DR; Duncan JS
    Epilepsy Res; 1994 Sep; 19(1):71-7. PubMed ID: 7813416
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
    Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
    Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Positron emission tomography studies of frontal lobe function: relevance to psychiatric disease.
    Frith C
    Ciba Found Symp; 1991; 163():181-91; discussion 191-7. PubMed ID: 1815891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.